Evidence map›Paper›PMID 41490010›Full record

Trial reportJAMA internal medicine2026

Nudges to Clinicians and Patients for Influenza Vaccines During Visits: The BE IMMUNE Randomized Clinical Trial.

Shivan J Mehta, Kimberly J Waddell, Kristin A Linn, Caitlin Brophy, Junning Liang, Sae-Hwan Park, Catherine Reitz, Keyirah Williams, Chaylin Couzens, Jonathan Staloff and 4 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in JAMA internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06057727 (BE IMMUNE), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06057727 nacompletednot on this map

BE IMMUNE: Behavioral Economics to IMprove and Motivate Vaccination Using Nudges Through the EHR

TypeinterventionalSponsorUniversity of PennsylvaniaRan2023 to 2024Enrolled80,039ConditionsBehavior, Health, Flu, Flu VaccinationArmsPre-visit patient text messaging, Default pended order, Monthly peer comparison feedback, High risk bidirectional pre-visit text messaging
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shivan J MehtaPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Kimberly J WaddellPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Kristin A LinnPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Caitlin BrophyPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Junning LiangPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Sae-Hwan ParkPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Catherine ReitzPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Keyirah WilliamsPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Chaylin CouzensUniversity of Washington, Seattle.
Jonathan StaloffUniversity of Washington, Seattle.
Andrew A WhiteUniversity of Washington, Seattle.
Corinne RhodesPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Joshua M LiaoThe University of Texas Southwestern Medical Center, Dallas.
Amol S NavathePerelman School of Medicine, University of Pennsylvania, Philadelphia.

Funding

BE IMMUNE: Behavioral Economics to Improve and Motivate vaccination Using Nudges through the EHRR33AG068945 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LIAO, JOSHUA M, MEHTA, SHIVAN JATIN · 2022 to 2024
$1.6M
HSRD VA IK2 HX003787NIA NIH HHS R33 AG068945
6 · The paper itself

Abstract

Importance: Annual influenza vaccination reduces burden of disease for older adults, but rates remain suboptimal. Objective: To evaluate if a multicomponent nudge intervention to clinicians and patients increases vaccine completion during primary care visits. Design, Setting, and Participants: The pragmatic BE IMMUNE (Behavioral Economics to Improve and Motivate Vaccination in Primary Care Using Nudges Through the Electronic Health Record) randomized clinical trial took place across 48 primary care clinics through Penn Medicine (Philadelphia, Pennsylvania) and UW Medicine (Seattle, Washington). Patients 50 years and older who were scheduled for a primary care visit and were due for an influenza vaccine within the active intervention period (September 25, 2023, to February 20, 2024) were included. Interventions: Clinics were randomized in a 2:1 ratio to receive (1) previsit text message reminders to patients, (2) an automatic pended order, and (3) monthly comparisons of panel vaccination rates to peer clinicians, or usual care. Additionally, patients in the intervention arm who were identified as high risk for noncompletion were individually randomized 1:1 to receive previsit bidirectional text messaging or a standard text reminder. Main Outcomes and Measures: The primary outcome was influenza vaccination during the visit. Results: Among 80 039 patients across 47 clinics, the mean (SD) age was 65.8 (10.2) years, and 56.0% were female while 43.6% were male. The adjusted odds ratio (AOR) for vaccine completion comparing intervention to usual care was 1.28 (97.5% CI, 1.13-1.45; adjusted P < .001). The probability of completion in the intervention was 31.4% compared to 26.4% under usual care, with a risk difference of 5.1 percentage points (97.5% CI, 2.6-7.5 percentage points; adjusted P < .001). The adjusted odds ratio comparing bidirectional vs standard text messaging among high-risk patients was not statistically significant (1.00; 97.5% CI, 0.98-1.02; adjusted P = .92). Conclusions and Relevance: In this randomized clinical trial, the multicomponent nudge resulted in a statistically significant higher rate of influenza vaccination during the primary care visit, but the bidirectional text messaging did not further increase vaccination in the high-risk group. Trial Registration: ClinicalTrials.gov Identifier: NCT06057727.

Indexed as

Influenza, HumanInfluenza VaccinesReminder SystemsText MessagingVaccinationAgedFemaleHumansMaleMiddle AgedPrimary Health CareInfluenza Vaccines

Identifiers

PMID41490010
PMCPMC12771388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.